logo
Plus   Neg
Share
Email

Bristol-Myers: Health Canada Approves DAKLINZA For Treatment Of Hepatitis C

Bristol-Myers Squibb Canada (BMY) reported that Health Canada has granted the company medication DAKLINZATM (daclatasvir) approval for the treatment of chronic hepatitis C infection. The company said the approval includes a Notice of Compliance for the treatment of adult patients with hepatitis C genotypes 1 and 2 with compensated liver disease including cirrhosis and a Notice of Compliance with conditions for the treatment of genotype 3 patients with compensated liver disease including cirrhosis.

Bristol-Myers Squibb Canada said the indication marks the first interferon and ribavirin-free all oral regimen for the treatment of genotype 3 patients to be approved in Canada.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hongkong Sun Rise Trading Ltd. has recalled about 151,400 units of Kobalt Cordless Electric chainsaws and about 106,520 units of Kobalt Cordless Electric pole saws for possible laceration hazard, according to two separate statements issued by the U.S. Consumer Product Safety Commission. These include 1,400 chainsaws and 120 pole saws sold in Canada. Branded food company Hormel Foods Corp. (HRL) announced Friday that its Hormel Black Label Breakfast Food Truck will hit the road with free sample event of the popular brand's new Hormel Black Label Oven-Baked Egg Bites. The samples come in three variants - with Bacon, with Chorizo and with Bacon and... United Airlines has rolled out an interactive online "Map Search" feature for its customers in collaboration with search giant Google. The new feature is powered by Google Flight Search Enterprise Technology. United is claimed to be the first airline in the U.S. to add this feature. The new feature, available on United.com, allows customers to easily search, compare and purchase flight tickets.
RELATED NEWS
Follow RTT